Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors
Rhea-AI Summary
Strata Critical Medical (NASDAQ:SRTA) appointed Will Cook to its Board of Directors, effective December 3, 2025. Mr. Cook also joins the Compensation and Nominating and Corporate Governance Committees. He currently serves as President and CEO of Vail Health and previously led University of Colorado Hospital and held senior roles at UPMC and Johns Hopkins Health System. Strata said Cook’s healthcare leadership and industry relationships will support scaling its end-to-end organ recovery and logistics platform and advancing its mission to increase organs available for transplant.
Mr. Cook holds a master’s in health administration from Washington University School of Medicine and a BA in business administration from Texas A&M University.
Positive
- Board appointment effective December 3, 2025
- Adds healthcare leadership experience from Vail Health and University of Colorado Hospital
- Named to Compensation and Nominating and Corporate Governance Committees
Negative
- None.
News Market Reaction
On the day this news was published, SRTA declined 1.13%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
SRTA was up 1.76% pre-news with strong volume. Several aviation/logistics peers like OMAB (+3.85%), CAAP (+2.34%), and ASLE (+1.74%) were also positive, but the momentum scanner did not flag a coordinated sector move, suggesting this board appointment was more company-specific.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Board appointment | Positive | -1.1% | Added experienced healthcare CEO Will Cook to Board and committees. |
| Nov 17 | Investor Day guidance | Positive | -7.1% | Provided 2026 guidance and 2027–2029 medium‑term financial framework. |
| Nov 10 | Q3 2025 earnings | Positive | +9.5% | Reported strong revenue growth, improved margins, raised 2025 guidance. |
| Oct 09 | Earnings call notice | Neutral | +0.8% | Announced Q3 2025 earnings release date and conference call details. |
| Sep 30 | Investor Day notice | Neutral | +2.0% | Announced scheduling and format details for 2025 Investor Day. |
Recent news with clearly positive fundamentals (notably Q3 earnings) has aligned with strong price gains, while strategic or guidance-focused events have sometimes seen negative near-term reactions.
Over the last few months, Strata Critical Medical has reported strong Q3 2025 growth, with revenue of $49.3M and raised 2025 revenue guidance to $185–195M, which corresponded with a 9.48% gain. In contrast, the 2025 Investor Day and medium-term guidance on Nov 17 and this same board appointment headline previously saw negative next‑day moves. Scheduling and event announcements in October and late September produced modest positive reactions. Today’s management news fits into an ongoing strategy of scaling its organ recovery and logistics platform.
Market Pulse Summary
This announcement highlights Strata’s focus on strengthening governance and healthcare expertise as it scales its organ recovery and logistics platform. Adding Will Cook, a sitting health system CEO, to the Board and key committees supports its growth and execution priorities. In context of recent strong Q3 results and medium‑term financial targets, investors may watch how Board composition, insider activity, and execution against those 2026 and 2029 goals evolve over time.
AI-generated analysis. Not financial advice.
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The Board of Directors (the “Board”) of Strata Critical Medical, Inc. (“Strata” or the “Company”), a leading provider of logistics and medical services in the organ transplant industry, today announced the appointment of Will Cook to the Board, effective December 3, 2025. Mr. Cook has also been appointed to the Compensation and Nominating and Corporate Governance Committees.
Mr. Cook is the President and Chief Executive Officer of Vail Health, a nonprofit community health care system headquartered in Vail, Colorado.
“We are very excited to welcome Will Cook to our board of directors,” said Melissa Tomkiel, Strata’s Co-Chief Executive Officer. “Will’s extensive experience in health care will be invaluable to us as we scale our end-to-end organ recovery and logistics platform throughout the country.”
“Will’s deep relationships within, and knowledge of the healthcare industry will be an incredible resource to us as we pursue our mission to increase the number of organs for transplant and explore other avenues to more broadly service the medical sector,” said Will Heyburn, Strata’s Co-Chief Executive Officer.
Prior to Vail Health, Mr. Cook served as President and CEO of University of Colorado Hospital, where he led major facility development projects including two hospitals in northern and southern Denver. Before that, he held senior leadership positions at the University of Pittsburgh Medical Center (UPMC) including Vice President of Transplant and Ambulatory Care at UPMC Presbyterian Shadyside Hospital. He held a variety of roles at Johns Hopkins Health System in Baltimore.
“It’s my honor to serve on the Board of Directors of Strata as we execute against our multi-pronged growth strategy while continuing to facilitate the life-saving work of our customers every day,” said Mr. Cook.
Mr. Cook received a master’s degree in health administration from Washington University School of Medicine and a Bachelor of Arts degree in Business Administration from Texas A&M University.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit www.srta.com.
Contacts
Mathew Schneider
investors@srta.com
FAQ
Who is Will Cook and why was he appointed to Strata Critical Medical's board (SRTA)?
When did Strata Critical Medical (SRTA) appoint Will Cook to the board?
Which board committees will Will Cook join at Strata Critical Medical (SRTA)?
What experience does Will Cook bring that could affect Strata Critical Medical (SRTA)?
Does Will Cook have formal healthcare education relevant to his Strata Critical Medical (SRTA) board role?
